{"slideshow_credits": null, "snippet": "Updated findings from one of the largest studies of prostate cancer screening show that the commonly used P.S.A. blood test did not save lives, although questions remain about whether younger men or those at very high risk for the disease might...", "abstract": "Updated findings from one of the largest studies of prostate cancer screening show that the commonly used P.S.A. blood test did not save lives, although questions remain about whether younger men or those at very high risk for the disease might benefit.", "section_name": "Health", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Tara", "role": "reported", "lastname": "PARKER-POPE", "rank": 1, "organization": ""}], "original": "By TARA PARKER-POPE"}, "web_url": "http://well.blogs.nytimes.com/2012/01/06/embargoed-no-benefit-from-prostate-cancer-screening/", "lead_paragraph": "Updated findings from one of the largest studies of prostate cancer screening show that the commonly used P.S.A. blood test did not save lives, although questions remain about whether younger men or those at very high risk for the disease might benefit.", "headline": {"main": "Prostate Cancer Screening Shows No Benefit", "kicker": "Well"}, "_id": "4fd3a2e28eb7c8105d8eb5ce", "word_count": 600, "multimedia": [], "pub_date": "2012-01-06T16:00:49Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "subject", "value": "Prostate Gland", "rank": "4"}, {"name": "subject", "value": "Prostate Cancer", "rank": "3"}, {"name": "subject", "value": "Medicine and Health", "rank": "2"}, {"name": "subject", "value": "Prostate Specific Antigen", "rank": "5"}, {"name": "type_of_material", "value": "News", "rank": "1"}, {"name": "subject", "value": "Tests (Medical)", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "Blog"}